Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings
Pasquale Lombardi(Università Cattolica del Sacro Cuore), Gennaro Daniele(Università Cattolica del Sacro Cuore)
Cited by 52
Related Papers
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial
|The Lancet Oncology|2021|148
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
|Gut|2024|36
List of Contributors
|Elsevier eBooks|2018|0